高危和低危人乳头瘤病毒基因型的相互作用与宫颈癌发病风险降低有关。

Malihe Hasanzadeh, Marzieh Rejali, Ghazaleh Khalili-Tanha, Mehraneh Mehramiz, Negar Yavari, Elham Nazari, Parnian Malakuti, Faezeh Maleki, Ghazale Ghorbannezhad, Mahdi Rafiei, Anahita Mirani, Negar Gholampoor-Shamkani, Hoda Saber, Leila Mousavi Seresht, Zohreh Emamdadi-Aliabad, Zahra Mahdian, Mahdieh Akbari, Gordon A Ferns, Ala-Eddin Al Moustafa, Amir Avan
{"title":"高危和低危人乳头瘤病毒基因型的相互作用与宫颈癌发病风险降低有关。","authors":"Malihe Hasanzadeh, Marzieh Rejali, Ghazaleh Khalili-Tanha, Mehraneh Mehramiz, Negar Yavari, Elham Nazari, Parnian Malakuti, Faezeh Maleki, Ghazale Ghorbannezhad, Mahdi Rafiei, Anahita Mirani, Negar Gholampoor-Shamkani, Hoda Saber, Leila Mousavi Seresht, Zohreh Emamdadi-Aliabad, Zahra Mahdian, Mahdieh Akbari, Gordon A Ferns, Ala-Eddin Al Moustafa, Amir Avan","doi":"10.2174/0118715265307980240826060516","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Cervical cancer is among the most common types of cancer in women and is associated with human papillomavirus (HPV) infection. The association between cervical cancer and high-risk HPV infection has been well documented. However, the effect of simultaneous infection with high- and low-risk HPV or low-risk HPV alone on the risk of developing cervical malignancy remains unanswered in guidelines.</p><p><strong>Method: </strong>We investigated the association of high and low-risk HPVs (HR or LR) genotypes with cervical carcinoma risk and pathological and cytological information in cases recruited from a population-based cohort study of 790 patients. Correlation matrix and t-test were used for analysis.</p><p><strong>Results: </strong>The percentage of HR+LR and HR-HPV16/18 were 9.30% and 11.20% in class II, 7.15% and 7.10% in class IV, and 7.15% and 5.80% in As-CUS smears. Interestingly, concurrent infection with HR-HPV and LR-HPV types led to a significant reduction in the risk of developing malignancy compared to the high-risk group (OR=0.3 (0.098-0.925), pvalue=0.04). The percentage of individuals with cervical malignancy was 10.2% and 28.2% within the co-infected and the HR-HPV participants.</p><p><strong>Conclusion: </strong>Our findings suggest that simultaneous infection with high- and low-risk HPV may reduce the risk of cervical malignancy.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Interaction of High- and Low-Risk Human Papillomavirus Genotypes is Associated with a Reduced Risk of Developing Cervical Cancer.\",\"authors\":\"Malihe Hasanzadeh, Marzieh Rejali, Ghazaleh Khalili-Tanha, Mehraneh Mehramiz, Negar Yavari, Elham Nazari, Parnian Malakuti, Faezeh Maleki, Ghazale Ghorbannezhad, Mahdi Rafiei, Anahita Mirani, Negar Gholampoor-Shamkani, Hoda Saber, Leila Mousavi Seresht, Zohreh Emamdadi-Aliabad, Zahra Mahdian, Mahdieh Akbari, Gordon A Ferns, Ala-Eddin Al Moustafa, Amir Avan\",\"doi\":\"10.2174/0118715265307980240826060516\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Cervical cancer is among the most common types of cancer in women and is associated with human papillomavirus (HPV) infection. The association between cervical cancer and high-risk HPV infection has been well documented. However, the effect of simultaneous infection with high- and low-risk HPV or low-risk HPV alone on the risk of developing cervical malignancy remains unanswered in guidelines.</p><p><strong>Method: </strong>We investigated the association of high and low-risk HPVs (HR or LR) genotypes with cervical carcinoma risk and pathological and cytological information in cases recruited from a population-based cohort study of 790 patients. Correlation matrix and t-test were used for analysis.</p><p><strong>Results: </strong>The percentage of HR+LR and HR-HPV16/18 were 9.30% and 11.20% in class II, 7.15% and 7.10% in class IV, and 7.15% and 5.80% in As-CUS smears. Interestingly, concurrent infection with HR-HPV and LR-HPV types led to a significant reduction in the risk of developing malignancy compared to the high-risk group (OR=0.3 (0.098-0.925), pvalue=0.04). The percentage of individuals with cervical malignancy was 10.2% and 28.2% within the co-infected and the HR-HPV participants.</p><p><strong>Conclusion: </strong>Our findings suggest that simultaneous infection with high- and low-risk HPV may reduce the risk of cervical malignancy.</p>\",\"PeriodicalId\":101326,\"journal\":{\"name\":\"Infectious disorders drug targets\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious disorders drug targets\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0118715265307980240826060516\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious disorders drug targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0118715265307980240826060516","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

导言:宫颈癌是女性最常见的癌症之一,与人类乳头瘤病毒(HPV)感染有关。宫颈癌与高危型人乳头瘤病毒感染之间的关系已得到充分证实。然而,同时感染高危和低危型 HPV 或仅感染低危型 HPV 对宫颈恶性肿瘤发病风险的影响仍未在指南中找到答案:我们调查了高危和低危HPV(HR或LR)基因型与宫颈癌风险、病理学和细胞学信息的关系,这些病例来自一项基于人群的队列研究,共有790名患者。分析采用了相关矩阵和 t 检验:结果:HR+LR和HR-HPV16/18在II级涂片中的比例分别为9.30%和11.20%,在IV级涂片中的比例分别为7.15%和7.10%,在As-CUS涂片中的比例分别为7.15%和5.80%。有趣的是,与高危组相比,同时感染 HR-HPV 和 LR-HPV 类型可显著降低罹患恶性肿瘤的风险(OR=0.3 (0.098-0.925),pvalue=0.04)。合并感染者和HR-HPV感染者中患宫颈恶性肿瘤的比例分别为10.2%和28.2%:我们的研究结果表明,同时感染高危和低危 HPV 可降低宫颈恶性肿瘤的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Interaction of High- and Low-Risk Human Papillomavirus Genotypes is Associated with a Reduced Risk of Developing Cervical Cancer.

Introduction: Cervical cancer is among the most common types of cancer in women and is associated with human papillomavirus (HPV) infection. The association between cervical cancer and high-risk HPV infection has been well documented. However, the effect of simultaneous infection with high- and low-risk HPV or low-risk HPV alone on the risk of developing cervical malignancy remains unanswered in guidelines.

Method: We investigated the association of high and low-risk HPVs (HR or LR) genotypes with cervical carcinoma risk and pathological and cytological information in cases recruited from a population-based cohort study of 790 patients. Correlation matrix and t-test were used for analysis.

Results: The percentage of HR+LR and HR-HPV16/18 were 9.30% and 11.20% in class II, 7.15% and 7.10% in class IV, and 7.15% and 5.80% in As-CUS smears. Interestingly, concurrent infection with HR-HPV and LR-HPV types led to a significant reduction in the risk of developing malignancy compared to the high-risk group (OR=0.3 (0.098-0.925), pvalue=0.04). The percentage of individuals with cervical malignancy was 10.2% and 28.2% within the co-infected and the HR-HPV participants.

Conclusion: Our findings suggest that simultaneous infection with high- and low-risk HPV may reduce the risk of cervical malignancy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Diagnosis of Genital Tuberculosis Unveiled by Utero-Cutaneous Fistula and Superimposed MRSA Infection: A Case Report. Streptococcal Toxic Shock Syndrome (STSS) Secondary to Monoarticular Septic Arthritis Leading to Multiorgan Failure in a Patient without Underlying Comorbidities: Emphasizing Early Diagnosis and Management Strategies. Tissue Plasminogen Activator for COVID-19-induced Severe Acute Respiratory Distress Syndrome: A Controlled Clinical Trial. A Clinical Multicenter Trial of Recombinant Human Interferon Gamma in Tuberculosis (GAM2022) Experience with the Use of Human Recombinant Interferon Gamma in TB Practice. A Case Report of Salmonella enterica Meningitis in an Infant: A Rare Entity not to Forget.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1